beluuga.ai
JA
Try the Live Demo →
Overview
-

MabGenesis（株）

Market Cap
¥—B
EV
¥—B
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
—
LTM EV/EBIT
—
LTM PER
—
LTM PBR
—
No price data
Stock data unavailable
This company is listed on a regional exchange (Nagoya/Fukuoka/Sapporo) and is not distributed via J-Quants (JPX). Stock price, market cap, and EV-based multiples are not available. Financial data from public filings (P&L, BS, directors, etc.) remains accurate for analysis.
AI Briefing
Generating insights…
Performance & Balance
Shareholders
Top 10 hold 88.7%
1
Nagoya University-Tokai Regional Universities Venture No. 2 Investment Limited Partnership
15.96%
2
Kyushu Regional Reconstruction Support Investment Limited Partnership
13.03%
3
Katsuhiro SHINJO
12.43%
4
Hitoshi KUROSAWA
12.12%
5
Axil Life Science & Healthcare Fund No. 2 Investment Limited Partnership
8.14%
6
Nobukazu KOIZUMI
6.64%
7
Anniversaire Holdings Co., Ltd.
6.51%
8
Kazuhiro MORISHITA
6.25%
9
Yuichiro SHIBASAKI
4.40%
10
Miyagin Miyazaki University Dream Support Investment Limited Partnership
3.26%
Management
8 officers
Katsuhiro SHINJO
Representative Director
Nobukazu KOIZUMI
Director
Ryu MAEDA
Director
Akiyoshi KAWAI
Director
Tokio YAMAGUCHI
Director
Toshiaki KUDO
Full-time Audit & Supervisory Board Member
Hiroshige HATSUZAWA
Audit & Supervisory Board Member
Daisuke NISHII
Audit & Supervisory Board Member
Large Shareholding Reports
No filings
Disclosures
No disclosures
Primary Source Filings
EDINETAmended
2026-10-22
Amended Securities Registration Statement
View PDF →
EDINETAmended
2026-10-14
Amended Securities Registration Statement
View PDF →
EDINET
2026-09-28
Securities Registration Statement
View PDF →
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →